Page last updated: 2024-08-16

thioridazine and cyclin d1

thioridazine has been researched along with cyclin d1 in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Byun, HJ; Dong, SM; Kang, S; Kim, BR; Park, MS; Rho, SB; Trink, B1

Other Studies

1 other study(ies) available for thioridazine and cyclin d1

ArticleYear
Thioridazine induces apoptosis by targeting the PI3K/Akt/mTOR pathway in cervical and endometrial cancer cells.
    Apoptosis : an international journal on programmed cell death, 2012, Volume: 17, Issue:9

    Topics: Adaptor Proteins, Signal Transducing; Antineoplastic Agents; Apoptosis; Caspase 3; Cell Cycle Proteins; Cell Division; Cell Line, Tumor; Cell Survival; Cyclin A; Cyclin D1; Cyclin-Dependent Kinase 4; Cyclin-Dependent Kinase Inhibitor p21; Cyclin-Dependent Kinase Inhibitor p27; Down-Regulation; Endometrial Neoplasms; Female; HeLa Cells; Humans; Phosphatidylinositol 3-Kinases; Phosphoproteins; Phosphorylation; Proto-Oncogene Proteins c-akt; Ribosomal Protein S6 Kinases, 70-kDa; Signal Transduction; Thioridazine; TOR Serine-Threonine Kinases; Uterine Cervical Neoplasms

2012